Botanical species · safety record

Robinia pseudoacacia

The EFSA Compendium of Botanicals holds 4 constituent measurements and 4 adverse-effect records for Robinia pseudoacacia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Robinia pseudoacacia L.

4Constituent measurements
4Safety records
5Cited sources
45Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 45 licensed products naming Robinia pseudoacacia as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Bark
  • Bark of young twigs
  • Fresh bark of young branches
  • Fresh bark of young twigs
  • Écorce de jeunes rameaux

What the records describe

Constituents measured

  • Canavanine1
  • Cyanamide including salts expressed as cyanamide1
  • Lectins1
  • Phasin1

Plant parts

  • Unspecified4
  • Leaves2
  • Aerial part of plants1
  • Roots and other underground parts1

Preparations

  • Solvent extraction2

Effect types

  • Systemic2
  • Digestive1

Target tissues

  • Digestive2
  • Neurologic1
  • Neurologic: central nervous system1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CanavanineLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Cyanamide including salts expressed as cyanamideLeavesSolvent extraction132.6 Milligram/gramGC-MSResolve DOI
LectinsUnspecifiedResolve DOI
PhasinUnspecifiedResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DigestiveNeurologicRoots and other underground partsHorse (as animal)Case reportResolve DOI
Not statedDigestiveUnspecifiedHuman (as organism)Case reportResolve DOI
SystemicDigestiveAerial part of plantsHorse (as animal)Case reportNo resolvable identifier
SystemicNeurologic: central nervous systemUnspecifiedHuman (as organism)Case reportNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Kaland, Mingzohn Ellen., Klein-Schwartz, Wendy., Anderson, Bruce D. Toxalbumin exposures: 12 years' experience of US poison centers. Toxicon, 2015, vol. 99, p. 125-129. DOI
  2. Botha, CJ., Naude, TW. Plant poisonings and mycotoxicoses of importance in horses in southern Africa . Journal of the south african veterinary association-tydskrif van die suid-afrikaanse veterinere vereniging, 2002, vol. 73, no. 3, p. 91-97.
  3. Costa Bou X., Soler i Ros JM., Seculi Palacios JL. Poisoning by Robinia pseudoacacia . Intoxicaci�n por Robinia pseudoacacia.. Anales espanoles de pediatria, 1990, vol. 32, no. 1, p. 68-9.
  4. Vanschandevijl, K., van Loon, G., Lefere, L., Deprez, P. Black locust (Robinia pseudoacacia) intoxication as a suspected cause of transient hyperammonaemia and enteral encephalopathy in a pony. Equine veterinary education, 2010, vol. 22, no. 7, p. 336-339. DOI
  5. Kamo, Tsunashi., Tokuoka, Yoshinori., Miyazaki, Masahisa. Quantification of Canavanine, 2-Aminoethanol, and Cyanamide in Aphis craccivora and its Host Plants, Robinia pseudoacacia and Vicia angustifolia: Effects of These Compounds on Larval Survivorship of Harmonia axyridis . Journal of chemical ecology, 2012, vol. 38, no. 12, p. 1552-1560. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue